Novacyt Revenues Full Year 2015

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its unaudited revenues for the full year to December 2015. Download press release

Visit Page

Novacyt to collaborate to validate HPV testing with NOVAprep® technology

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has announced it will validate the NOVAprep® liquid-based cytology platform with Abbott’s RealTime High Risk HPV (Human papillomavirus) assay. Download press release

Visit Page

Novacyt Named in Deloitte Technology Fast 500

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 500 for Europe, Middle East and Africa. Download press release

Visit Page